NCT00527267 - Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects | Biotech Hunter

Enrollment

320

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions

Hyperparathyroidism

Interventions

DRUG

Placebo

30 mg placebo once daily orally 60 mg placebo once daily orally 90 mg placebo once daily orally 120 mg placebo once daily orally 180 mg placebo once daily orally

DRUG

AMG 073

30 mg AMG 073 once daily 60 mg AMG 073 once daily 90 mg AMG 073 once daily 120 mg AMG 073 once daily 180 mg AMG 073 once daily